Professor Adnan Tufail, MBBS, MD, FRCOphth, is one of the leading ophthalmic surgeons in the UK. His areas of interest and research include Medical Retina, Uveitis and Cataract, and he specialises in medical retina disorders, and cataract surgery in patients with retinal disorders. He is the clinical and research lead at Moorfields Eye Hospital in London for age-related macular degeneration (AMD). In fact, Adnan has been a Consultant Ophthalmologist at Moorfields Eye Hospital NHS Foundation Trust from 2002, and is an Honorary Senior Lecturer at The Institute of Ophthalmology, UCL (University College London).
Professor Tufail has achieved a lot in his career. Not only is he one of the best surgeons in the UK, he was a co-principal investigator in the seminal ABC Trial that focused on examining bevacizumab for neovascular AMD, which had a profound effect on eyecare in the UK. In fact, this ABC Trial became a cornerstone for and critical in defining the use of anti-VEGF treatment protocols for wet-AMD therapy within the NHS.
He is also Deputy Lead of the large 16million euro study of dry age-related macular degeneration MACUSTAR – you can find more info about this important research here.
His primary areas of interest are novel therapies for dry AMD, choroidal neovascularisation (including wet AMD) and diabetic retinopathy and has published more than 80 peer-reviewed journal articles on his research. He is involved in laboratory as well as clinical research into treating a number of rare retinal diseases. Prof Tufail has research interests in novel treatments of diabetic retinopathy and is involved in translational drug and cellular therapy development, imaging and pathology of diabetic retinopathy. In addition he is involved in projects on big data and machine learning applications to diabetic eye disease and screening.
Read about Professor Tufail being Voted one of the top 10 most influential ophthalmologists in the world in this Ophthalmologist Power List article.
Further details of Professor Tufail’s career and training is in the table below
- IRIS (UCL Institutional Research Information Service Profile)
- UCL biography (UCL Institute of Ophthalmology Bio)
- Scientific articles on diabetic retinopathy (American Association of Ophthalmology)
- Automated Diabetic Retinopathy Image Assessment Software (American Association of Ophthalmology)
- Myopia complications (British Journal of Ophthalmology)
- Ranibizumab in Myopic Choroidal Neovascularization: The 12-Month Results from the REPAIR Study (American Association of Ophthalmology)
First medical qualification: 1989. Initial medical training:Guy’s Hospital Medical School, University of London
Further key experience: Two-year fellowship in medical retina at Moorfields Eye Hospital as well as a period with Prof Gass and the Vanderbilt Medical Center, Nashville, USA. Spent 2½ years at the Jules Stein Eye Hospital, Los Angeles, USA, undertaking clinical training in uveitis as well as completing a higher research degree.Clinical and research lead at Moorfields Eye Hospital for treatments for age-related macular degeneration
- Fellow of the Royal College of Ophthalmologists
- Member of The American Society of Retina Specialists
- Member of the European Vision Institute Retina Panel
- Consultant Ophthalmologist Moorfields Eye Hospital
- Honorary Senior Lecturer at The Institute of Ophthalmology, University College London
- NIHR Theme Lead for Translational Research in Age-related Macular Degeneration
- Guys Hospital Medical School, University of London
- Moorfields Eye Hospital NHS Foundation Trust
- Moorfields/North Thames Rotation for Higher Surgical Training, fellowships in
- Uveitis (1995-1997) Jules Stein Eye Institute UCLA with Professor Gary Holland, and
- Medical retina 2000-2002, Moorfields Eye Hospital
You can contact his London private practices here for more information about your vision care.